Logo image of GUG

GUGGENHEIM ACTIVE ALLOCATION (GUG) Stock Price, Quote, News and Overview

NYSE:GUG - New York Stock Exchange, Inc. - US40170T1060 - Currency: USD

15.693  -0.04 (-0.24%)

Fundamental Rating

1

GUG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. GUG may be in some trouble as it scores bad on both profitability and health. GUG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GUG had positive earnings in the past year.
GUG had a negative operating cash flow in the past year.
GUG Yearly Net Income VS EBIT VS OCF VS FCFGUG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -200M -400M -600M -800M

1.2 Ratios

Industry RankSector Rank
ROA 11.78%
ROE 15.15%
ROIC 4.04%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GUG Yearly ROA, ROE, ROICGUG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10

1.3 Margins

Industry RankSector Rank
OM 62.96%
PM (TTM) 148.15%
GM 63.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GUG Yearly Profit, Operating, Gross MarginsGUG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 100 -100 -200 -300 -400

More info and screens

1

2. Health

2.1 Basic Checks

GUG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GUG Yearly Shares OutstandingGUG Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M
GUG Yearly Total Debt VS Total AssetsGUG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.79, we must say that GUG is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.26 indicates that GUG is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z 1.79
ROIC/WACCN/A
WACCN/A
GUG Yearly LT Debt VS Equity VS FCFGUG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 500M -500M

2.3 Liquidity

A Current Ratio of 0.02 indicates that GUG may have some problems paying its short term obligations.
A Quick Ratio of 0.02 indicates that GUG may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
GUG Yearly Current Assets VS Current LiabilitesGUG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

GUG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.12%, which is quite impressive.
The Revenue has grown by 10.44% in the past year. This is quite good.
EPS 1Y (TTM)67.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.36%
Revenue 1Y (TTM)10.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.15%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GUG Yearly Revenue VS EstimatesGUG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.43, the valuation of GUG can be described as very cheap.
When comparing the Price/Earnings ratio of GUG to the average of the S&P500 Index (26.86), we can say GUG is valued rather cheaply.
Industry RankSector Rank
PE 6.43
Fwd PE N/A
GUG Price Earnings VS Forward Price EarningsGUG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GUG Per share dataGUG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.25%, GUG is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.43, GUG pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.25%

5.2 History

GUG has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
GUG Yearly Dividends per shareGUG Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1

5.3 Sustainability

58.75% of the earnings are spent on dividend by GUG. This is a bit on the high side, but may be sustainable.
DP58.75%
EPS Next 2YN/A
EPS Next 3YN/A
GUG Yearly Income VS Free CF VS DividendGUG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 -200M -400M -600M -800M
GUG Dividend Payout.GUG Dividend Payout, showing the Payout Ratio.GUG Dividend Payout.PayoutRetained Earnings

More info and screens

GUGGENHEIM ACTIVE ALLOCATION

NYSE:GUG (6/26/2025, 8:04:00 PM)

15.693

-0.04 (-0.24%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners27.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change3.1%
Market Cap517.56M
AnalystsN/A
Price TargetN/A
Short Float %0.07%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield 9.25%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP58.75%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-13 2025-06-13 (0.11875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.43
Fwd PE N/A
P/S 9.58
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)2.44
EY15.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.88
OCFYN/A
SpS1.64
BVpS16.01
TBVpS16.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 15.15%
ROCE 6.42%
ROIC 4.04%
ROICexc 4.04%
ROICexgc 4.06%
OM 62.96%
PM (TTM) 148.15%
GM 63.07%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 3.76
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 1.79
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.15%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-20.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-20.67%
OCF growth 3YN/A
OCF growth 5YN/A